Axa S.A. Has $81.38 Million Stock Holdings in Veeva Systems Inc. (NYSE:VEEV)

AXA S.A. lowered its stake in Veeva Systems Inc. (NYSE:VEEV - Free Report) by 11.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 387,055 shares of the technology company's stock after selling 51,822 shares during the quarter. AXA S.A. owned about 0.24% of Veeva Systems worth $81,378,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Veeva Systems by 72.5% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 119 shares of the technology company's stock valued at $25,000 after purchasing an additional 50 shares during the period. Centricity Wealth Management LLC acquired a new stake in Veeva Systems in the fourth quarter valued at $25,000. Smithfield Trust Co raised its position in Veeva Systems by 145.5% during the fourth quarter. Smithfield Trust Co now owns 135 shares of the technology company's stock worth $27,000 after acquiring an additional 80 shares during the last quarter. Avion Wealth lifted its stake in Veeva Systems by 635.0% in the 4th quarter. Avion Wealth now owns 147 shares of the technology company's stock valued at $30,000 after buying an additional 127 shares in the last quarter. Finally, Retirement Wealth Solutions LLC acquired a new position in Veeva Systems in the 4th quarter valued at about $31,000. 88.20% of the stock is owned by hedge funds and other institutional investors.

Veeva Systems Price Performance

Shares of NYSE:VEEV traded up $0.44 during midday trading on Monday, reaching $236.93. The company's stock had a trading volume of 585,201 shares, compared to its average volume of 1,077,503. Veeva Systems Inc. has a fifty-two week low of $170.25 and a fifty-two week high of $258.93. The business's fifty day simple moving average is $226.72 and its 200-day simple moving average is $224.87. The company has a market capitalization of $38.55 billion, a P/E ratio of 58.50, a P/E/G ratio of 1.89 and a beta of 1.05.

Insider Buying and Selling at Veeva Systems

In other news, SVP Jonathan Faddis sold 787 shares of the firm's stock in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $226.20, for a total transaction of $178,019.40. Following the sale, the senior vice president now owns 8,668 shares of the company's stock, valued at $1,960,701.60. This trade represents a 8.32 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Timothy S. Cabral sold 3,882 shares of the firm's stock in a transaction that occurred on Friday, April 4th. The stock was sold at an average price of $216.83, for a total transaction of $841,734.06. Following the sale, the director now owns 5,500 shares in the company, valued at $1,192,565. This trade represents a 41.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 5,869 shares of company stock worth $1,284,917. Insiders own 10.50% of the company's stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on the company. Morgan Stanley lifted their price objective on Veeva Systems from $195.00 to $201.00 and gave the company an "underweight" rating in a research report on Thursday, March 6th. Needham & Company LLC restated a "buy" rating and set a $270.00 price objective on shares of Veeva Systems in a research note on Thursday, March 6th. Stephens reiterated an "overweight" rating and issued a $280.00 target price on shares of Veeva Systems in a research note on Thursday, March 6th. The Goldman Sachs Group lowered Veeva Systems from a "buy" rating to a "sell" rating and reduced their price target for the stock from $261.00 to $200.00 in a research report on Thursday, January 23rd. Finally, StockNews.com raised shares of Veeva Systems from a "hold" rating to a "buy" rating in a research report on Monday, February 17th. Two equities research analysts have rated the stock with a sell rating, eight have given a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $254.92.

About Veeva Systems

Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.